Author | Jeffrey A. Sosman, MD | OncLive

Author | Jeffrey A. Sosman, MD

Articles

Dr. Sosman on the Mechanism of Action of Ipilimumab

September 24, 2013

Video

Jeffrey A. Sosman, MD, professor of medicine, Director, Melanoma and Tumor Immunotherapy Program, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, describes the mechanism of action of ipilimumab in patients with melanoma.

Dr. Sosman on Immunotherapy in Melanoma and Renal Cancer

August 28, 2013

Video

Jeffrey A. Sosman, MD, Professor of Medicine, Director, Melanoma and Tumor Immunotherpay Program, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, discusses how immunotherapies work in patients with melanoma or renal cancer.

x